Open an account

Picard Medical

PMI · NYSE American

$10.48−$4.97 (−32.17%)TodayMarket closed ·
Prev close $15.45

About PMI

Picard Medical, Inc. is a medical technology company, which manufactures and sells the only U.S. FDA, and Health Canada approved implantable SynCardia TAH. The company is headquartered in Tucson, Arizona and currently employs 75 full-time employees. The company went IPO on 2025-08-29. SynCardia is a medical technology company that manufactures and sells the only United States Food and Drug Administration (FDA) and Health Canada-approved implantable total artificial heart (SynCardia TAH). The SynCardia TAH is a biventricular replacement device that consists of the SynCardia TAH implant, an external pneumatic driver that delivers precisely calibrated pulses of air to drive the implant, and drivelines that connect the driver to the implant. The SynCardia TAH implant is a system that consists of two independent artificial ventricles which are powered by an external pneumatic driver. Each artificial ventricle is made of a semi-rigid polyurethane housing and a rigid polyurethane base, with a four-layer flexible polyurethane diaphragm separating the blood chamber from the air chamber.

Employees
75
Headquarters
Tucson, Arizona
Listed
Aug 29, 2025
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
picardmedical.com

PMI key statistics

Market cap
24.51M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
527.38K
Volume
1.01M
Open price
$15.20
High today
$17.47
Low today
$10.14
52 Week high
$684.00
52 Week low
$2.65

Picard Medical (PMI) at a glance

As of Oct 20, 2026, Picard Medical (PMI) shares are priced at $10.48, giving the company a market cap of 24.51M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $10.14 and $17.47. The current price is 3.4% above the day's low and 40.0% below its high.

Volume so far is 1.01M shares, above the average of 527.38K shares a day.

Over the past year Picard Medical has ranged from $2.65 to $684.00, and now sits 1% of the way up that range.

The average analyst price target is $0.00, 100.0% below the current price, from 1 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

0%of 1 analyst rating say Buy
  • Buy0.0%
  • Hold100.0%
  • Sell0.0%
Price target · 1 analystsAvg $0.00
Low
$0.00
Now
$10.48
High
$0.00

PMI news

  • 12 Health Care Stocks Moving In Tuesday's After-Market Session

  • Press releasePRNewswire

    Kuehn Law Encourages Investors of Picard Medical Inc. to Contact Law Firm

  • Press releaseGlobe Newswire

    PICARD MEDICAL INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Picard Medical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

  • 12 Health Care Stocks Moving In Tuesday's Intraday Session

  • 12 Health Care Stocks Moving In Monday's Intraday Session

  • Lekha Gupta

    Why Is Picard Medical Stock Gaining Monday?

  • Rishabh Mishra

    Stock Market Today: Dow Jones, S&P 500, Nasdaq 100 Futures Slip Ahead of Data-Heavy Week, Nvidia Earnings, and Jackson Hole—BABA, PMI, BIRK in Focus (UPDATED)

  • 12 Health Care Stocks Moving In Friday's After-Market Session

Similar companies

Companies in the same industry as Picard Medical

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.